Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report.

Authors

Amanda J Skwara, Thomas Jefferson University
Russell J Schilder, Thomas Jefferson UniversityFollow
Allison Zibelli, Thomas Jefferson UniversityFollow
Norman G Rosenblum, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

1-1-2013

Comments

This article has been peer reviewed. It was published in: Gynecologic Oncology Case Reports

2013 November; 6: 7–9.

The published version is available at DOI: 10.1016/j.gynor.2013.06.005. Copyright © Elsevier Inc.

Abstract

•44 year old woman treated with bevacizumab for metastatic epithelial ovarian cancer•The patient experienced vaginal cuff dehiscence and evisceration at 8 months post-operatively.•Metastasis at the surgical site and chronic inflammation implicated.

Recommended Citation

Skwara, Amanda J; Schilder, Russell J; Zibelli, Allison; and Rosenblum, Norman G, "Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report." (2013). Department of Medical Oncology Faculty Papers. Paper 26.
https://jdc.jefferson.edu/medoncfp/26

PubMed ID

24371706